Why is Rubicon Research Ltd ?
1
With a growth in Net Profit of 67.93%, the company declared Very Positive results in Sep 26
- The company has declared positive results for the last 3 consecutive quarters
- NET SALES(Q) Highest at Rs 576.38 cr
- PBDIT(Q) Highest at Rs 144.08 cr.
- PBT LESS OI(Q) Highest at Rs 114.63 cr.
2
Stock is technically in a Mildly Bullish range
- A key technical factor - Bollinger Band has been Bullish since 25 Sep 2026
3
Market Beating Performance
- The stock has generated a return of 147.34% in the last 1 year, much higher than market (BSE500) returns of 0.37%
How much should you buy?
- Overall Portfolio exposure to Rubicon Research should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Rubicon Research for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Rubicon Research
147.34%
3.27
45.03%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
43.30%
EBIT Growth (5y)
75.22%
EBIT to Interest (avg)
8.72
Debt to EBITDA (avg)
1.44
Net Debt to Equity (avg)
0.15
Sales to Capital Employed (avg)
1.10
Tax Ratio
22.03%
Dividend Payout Ratio
0.23%
Pledged Shares
0
Institutional Holding
24.73%
ROCE (avg)
24.61%
ROE (avg)
22.94%
Valuation Key Factors 
Factor
Value
P/E Ratio
88
Industry P/E
40
Price to Book Value
20.12
EV to EBIT
64.82
EV to EBITDA
57.43
EV to Capital Employed
17.56
EV to Sales
13.67
PEG Ratio
NA
Dividend Yield
0.09%
ROCE (Latest)
27.10%
ROE (Latest)
22.94%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
Bollinger Bands
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
No Trend
Technical Movement
28What is working for the Company
NET SALES(Q)
Highest at Rs 576.38 cr
PBDIT(Q)
Highest at Rs 144.08 cr.
PBT LESS OI(Q)
Highest at Rs 114.63 cr.
PAT(Q)
Highest at Rs 90.48 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 25.00%
EPS(Q)
Highest at Rs 5.47
-4What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Rubicon Research
Net Sales - Quarterly
Highest at Rs 576.38 cr and Grown
each quarter in the last five quartersMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 144.08 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 114.63 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 90.48 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 25.00%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 114.63 cr has Grown at 27.9% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 89.65 CrMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 90.48 cr has Grown at 25.6% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 72.06 CrMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 5.47
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)